Chapter 1. Preface
1.1. Report Description
1.1.1. Study Purpose
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I – Secondary Research
1.3.2. Phase II – Primary Research
1.3.3. Phase III – Expert Panel Review
1.3.4. Assumptions
1.4. Market Segmentation
Chapter 2. Executive Summary
2.1. Global PV Market Portraiture
2.2. Global PV Market, by Vaccine Type, 2017 (US$ Mn)
2.3. Global PV Market, by Product Type, 2017 (US$ Mn)
2.4. Global PV Market, by Geography, 2017 (US$ Mn)
Chapter 3. Pneumococcal Vaccines (PV) Market Dynamics and Outlook
3.1. Market Overview
3.2. Drivers
3.3. Challenges
3.4. Opportunities
3.5. Attractive Investment Proposition, by Geography, 2017
3.6. Competitive Analysis: Global PV Market, by Key Players, 2017
Chapter 4. Global Pneumococcal Vaccines (PV) Market, by Vaccine Type, 2016-2026 (US$ Mn)
4.1. Overview
4.2. Pneumococcal Conjugate Vaccine
4.3. Pneumococcal Polysaccharide Vaccine
Chapter 5. Global Pneumococcal Vaccines (PV) Market, by Product Type, 2016 – 2026 (US$ Mn)
5.1. Overview
5.2. 10-valent PCV
5.3. 13-valent PCV
5.4. 23-valent PPSV
5.5. Pipeline Analysis
5.5.1. Phase III Analysis
5.5.1.1. 15-valent PCV
5.5.1.2. 20-valent PCV
5.5.2. Tabular Representation of Phase I and Phase II Vaccines
Chapter 6. Global Pneumococcal Vaccines (PV) Market, by Geography, 2016 – 2026 (US$ Mn)
6.1. North America PV Market Analysis, 2016 – 2026
6.1.1. North America PV Market, by Vaccine Type, 2016 – 2026 (US$ Mn)
6.1.2. North America PV Market, by Product Type, 2016 – 2026 (US$ Mn)
6.1.3. North America PV Market, by Country, 2016 – 2026 (US$ Mn)
6.1.3.1. U.S.
6.1.3.2. Canada
6.2. Europe PV Market Analysis, 2016 – 2026
6.2.1. Europe PV Market, by Vaccine Type, 2016 – 2026 (US$ Mn)
6.2.2. Europe PV Market, by Product Type, 2016 – 2026 (US$ Mn)
6.2.3. Europe PV Market, by Country/Region, 2016 – 2026 (US$ Mn)
6.2.3.1. U.K.
6.2.3.2. Germany
6.2.3.3. Rest of Europe
6.3. Asia Pacific PV Market Analysis, 2016 – 2026
6.3.1. Asia Pacific PV Market, by Vaccine Type, 2016 – 2026 (US$ Mn)
6.3.2. Asia Pacific PV Market, by Product Type, 2016 – 2026 (US$ Mn)
6.3.3. Asia Pacific PV Market, by Country/Region, 2016 – 2026 (US$ Mn)
6.3.3.1. China
6.3.3.2. Japan
6.3.3.3. Rest of Asia Pacific
6.4. Latin America PV Market Analysis, 2016 – 2026
6.4.1. Latin America PV Market, by Vaccine Type, 2016 – 2026 (US$ Mn)
6.4.2. Latin America PV Market, by Product Type, 2016 – 2026 (US$ Mn)
6.4.3. Latin America PV Market, by Country/Region, 2016 – 2026 (US$ Mn)
6.4.3.1. Brazil
6.4.3.2. Mexico
6.4.3.3. Rest of Latin America
6.5. Middle East & Africa PV Market, 2016 – 2026
6.5.1. Middle East & Africa PV Market, by Vaccine Type, 2016 – 2026 (US$ Mn)
6.5.2. Middle East & Africa PV Market, by Product Type, 2016 – 2026 (US$ Mn)
6.5.3. Middle East & Africa PV Market, by Region, 2016 – 2026 (US$ Mn)
6.5.3.1. GCC
6.5.3.2. Rest of Middle East & Africa
Chapter 7. Company Profiles
7.1. Pfizer, Inc.
7.1.1. Business Description
7.1.2. Financial Information (Subject to Data Availability)
7.1.3. Product Portfolio
7.1.4. News Coverage
7.2. GlaxoSmithKline PLC
7.3. Merck & Co., Inc.
List of Figures
FIG 1. Pneumococcal Vaccines (PV) Market: Research Methodology
FIG 2. PV Market Segmentation
FIG 3. Global PV Market, by Vaccine Type, 2017 (US$ Mn)
FIG 4. Global PV Market, by Product Type, 2017 (US$ Mn)
FIG 5. Global PV Market, by Geography, 2017 (US$ Mn)
FIG 6. Attractive Investment Proposition, by Geography, 2017
FIG 7. Competitive Analysis: Global PV Market, by Key Players, 2017
FIG 8. Global Pneumococcal Conjugate Vaccines (PCV) Market, 2016-2026 (US$ Mn)
FIG 9. Global Pneumococcal Polysaccharide Vaccines (PPSV) Market, 2016-2026(US$ Mn)
FIG 10. Global 10-valent PCV Market in Pneumococcal Vaccines, 2016-2026(US$ Mn)
FIG 11. Global 13-valent PCV Market in Pneumococcal Vaccines, 2016-2026(US$ Mn)
FIG 12. Global 23-valent PPSV Market in Pneumococcal Vaccines, 2016-2026(US$ Mn)
FIG 13. Global 15-valent PCV Market in Pneumococcal Vaccines, 2016-2026(US$ Mn)
FIG 14. Global 20-valent PCV Market in Pneumococcal Vaccines, 2016-2026(US$ Mn)
FIG 15. U.S. PV Market, 2016-2026 (US$ Mn)
FIG 16. Canada PV Market, 2016-2026 (US$ Mn)
FIG 17. U.K. PV Market, 2016-2026 (US$ Mn)
FIG 18. Germany PV Market, 2016-2026 (US$ Mn)
FIG 19. Rest of Europe PV Market, 2016-2026 (US$ Mn)
FIG 20. China PV Market, 2016-2026 (US$ Mn)
FIG 21. Japan PV Market, 2016-2026 (US$ Mn)
FIG 22. Rest of Asia Pacific PV Market, 2016-2026 (US$ Mn)
FIG 23. Brazil PV Market, 2016-2026 (US$ Mn)
FIG 24. Mexico PV Market, 2016-2026 (US$ Mn)
FIG 25. Rest of Latin America PV Market, 2016-2026 (US$ Mn)
FIG 26. GCC PV Market, 2016-2026 (US$ Mn)
FIG 27. Rest of Middle East & Africa PV Market, 2016-2026 (US$ Mn)
List of Tables
TABLE 1 Global Pneumococcal Vaccines (PV) Market Portraiture
TABLE 2 Global Pneumococcal Vaccines Discovery Market, by Vaccine Type, 2016 – 2026 (US$ Mn)
TABLE 3 Global PV Market, by Product Type, 2016 – 2026 (US$ Mn)
TABLE 4 Pipeline Analysis: Phase I & II Vaccines
TABLE 5 Global PV Market, by Geography, 2016 – 2026 (US$ Mn)
TABLE 6 North America PV Market, by Vaccine Type, 2016 – 2026 (US$ Mn)
TABLE 7 North America PV Market, by Product Type, 2016 – 2026 (US$ Mn)
TABLE 8 North America PV Market, by Country, 2016 – 2026 (US$ Mn)
TABLE 9 Europe PV Market, by Vaccine Type, 2016 – 2026 (US$ Mn)
TABLE 10 Europe PV Market, by Product Type, 2016 – 2026 (US$ Mn)
TABLE 11 Europe PV Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 12 Asia Pacific PV Market, by Vaccine Type, 2016 – 2026 (US$ Mn)
TABLE 13 Asia Pacific PV Market, by Product Type, 2016 – 2026 (US$ Mn)
TABLE 14 Asia Pacific PV Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 15 Latin America PV Market, by Vaccine Type, 2016 – 2026 (US$ Mn)
TABLE 16 Latin America PV Market, by Product Type, 2016 – 2026 (US$ Mn)
TABLE 17 Latin America PV Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 18 Middle East & Africa PV Market, by Vaccine Type, 2016 – 2026 (US$ Mn)
TABLE 19 Middle East & Africa PV Market, by Product Type, 2016 – 2026 (US$ Mn)
TABLE 20 Middle East & Africa PV Market, by Region, 2016 – 2026 (US$ Mn)
TABLE 21 Pfizer, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 22 Merck & Co., Inc..: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 23 GlaxoSmithKline Plc: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)